Abstract Details

Title The Effects of Pilates and Ai-Chi Methods in Patients with Multiple Sclerosis

Topic Neural Repair/Rehabilitation

Presentation(s) P04 - (-)

Poster/Presentation
Number 032

Objective

Background BACKGROUND: Although MS patients are often referred to the Pilates and Aquatherapy, the scientific evidences of these methods are not sufficient.

Design/Methods DESIGN/METHODS: Twenty-nine ambulatory female patients with MS (Kurtzke Expanded Disability Status Scale scores 0-4) were included to the study. Patients were divided into two groups as Pilates (n=18) and Ai-Chi (n=11). Both groups were instructed to do exercises 2 times/week for eight weeks. Static standing balance was measured with single leg balance test, functional mobility was measured with Timed-Up and Go test, upper (shoulder flexion-abduction, elbow flexion), lower extremity (hip flexion-abduction-adduction-extension, knee extension, dorsal flexion) muscle strength were assessed with hand-held dynamometer , the level of perceived balance confidence was evaluated with Activities Specific Balance Confidence Scale, fatigue was evaluated with Fatigue Severity Scale, mood was evaluated with Beck Depression Inventory, health related quality of life was evaluated using Nottingham Health Profile.

Results RESULTS: Static standing balance, functional mobility and mood were significantly improved in each group (p<0.05). Fatigue was significantly decreased in both groups (p<0.05). Whereas all of upper and lower extremity muscle strengths, the level of perceived balance confidence and quality of life were improved in Pilates group (p<0.05); no significant improvement were found (p>0.05) in Ai-Chi group on elbow flexion, hip adduction and dorsal flexion muscle strength, the level of perceived balance confidence and quality of life.

Conclusions CONCLUSIONS: According to these findings, each of two exercise approaches may improve balance, functional mobility and mood but Pilates seems to a better method than Ai-Chi for improving muscle strength, the level of perceived balance confidence and quality of life in patients with MS.

Authors/Disclosures
Ceyla Irkec, MD (Gazi University Hospital) PRESENTER	No disclosure on file
	No disclosure on file
Frauke Zipp, MD (University Medical Center Mainz)	Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Dr. Zipp has received research support from BMBF. The institution of Dr. Zipp has received research support from DFG. The institution of Dr. Zipp has received research support from PMSA. The institution of Dr. Zipp has received research support from Sanofi Genzyme. The institution of Dr. Zipp has received research support from UCB. The institution of Dr. Zipp has received research support from Eisai. The institution of Dr. Zipp has received research support from SK Life Science. The institution of Dr. Zipp has received research support from Abbott. The institution of Dr. Zipp has received research support from Actelion. The institution of Dr. Zipp has received research support from Bayer. The institution of Dr. Zipp has received research support from Servier. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Novartis. Dr. Zipp has received personal compensation in the range of $0-$499 for serving as a Reviewer with Universite de Geneve. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Oppenheim Förderpreis für Multiple Sklerose. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with EKFS. Dr. Zipp has a non-compensated relationship as a Associate Editor with Brain that is relevant to AAN interests or activities. Dr. Zipp has a non-compensated relationship as a Advisor with Science Translational Medicine that is relevant to AAN interests or activities.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Bijen Nazliel	No disclosure on file

��ɫ��

��ɫ��